Cargando…
Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study
Background: Population-based data on the prognosis of brain metastases at initial diagnosis of ovary cancer (OCBM) are currently lacking. Besides, the effective treatment for OCBM patients is still controversial now. The study aimed to explore the prognostic factors among OCBM. Methods: We retrospec...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255353/ https://www.ncbi.nlm.nih.gov/pubmed/32489480 http://dx.doi.org/10.7150/jca.44494 |
_version_ | 1783539721126805504 |
---|---|
author | Xi, Sujuan Li, Zaiyi Guo, Quan Lin, Wenjing Liang, Xiaokun Ma, Lin |
author_facet | Xi, Sujuan Li, Zaiyi Guo, Quan Lin, Wenjing Liang, Xiaokun Ma, Lin |
author_sort | Xi, Sujuan |
collection | PubMed |
description | Background: Population-based data on the prognosis of brain metastases at initial diagnosis of ovary cancer (OCBM) are currently lacking. Besides, the effective treatment for OCBM patients is still controversial now. The study aimed to explore the prognostic factors among OCBM. Methods: We retrospectively reviewed the OCBM patients from the Surveillance, Epidemiology, and End Result (SEER) database of the National Cancer Institute to investigate predictors of the presence of OCBM and its' prognostic factors related to all-cause mortality. We employed multivariable logistic and Cox regression analysis. Furthermore, to minimize the impact of potential confounding factors, we conducted a 1:1 propensity score matching (PSM) analysis. Results: A total of 29,512 cases of OC patients entered into the study, including 89 patients with brain metastases of ovarian cancer, which accounted for 0.30% of the entire cohort and 12.02% of the metastatic disease subset. We identified eight factors, including laterality, histology, surgery, radiotherapy, chemotherapy, and extracranial metastatic sites to bone, liver, and lung, as predictors of OCBM based on multivariable logistic regression among the entire cohort. The median survival time of OCBM was 2.0 months, and the interquartile range was 2.0-10.0 mo. The patients who received comprehensive treatment had better prognosis. Based on the multivariable Cox model, marital status, surgery, chemotherapy, and extensive therapy (including RSC, SC, and RC) were identified as predictors of OS. Besides, a new factor (brain metastasis) was identified by 1:1 PSM -based multiple Cox regression, apart from the above prognostic factors for OS. Conclusions: This study provided a population-based estimate of the proportion and prognosis for newly diagnosed ovary cancer with brain metastases. These findings may add materials to guidelines for preliminary screening and optimal treatment of OCBM patients. |
format | Online Article Text |
id | pubmed-7255353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-72553532020-06-01 Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study Xi, Sujuan Li, Zaiyi Guo, Quan Lin, Wenjing Liang, Xiaokun Ma, Lin J Cancer Research Paper Background: Population-based data on the prognosis of brain metastases at initial diagnosis of ovary cancer (OCBM) are currently lacking. Besides, the effective treatment for OCBM patients is still controversial now. The study aimed to explore the prognostic factors among OCBM. Methods: We retrospectively reviewed the OCBM patients from the Surveillance, Epidemiology, and End Result (SEER) database of the National Cancer Institute to investigate predictors of the presence of OCBM and its' prognostic factors related to all-cause mortality. We employed multivariable logistic and Cox regression analysis. Furthermore, to minimize the impact of potential confounding factors, we conducted a 1:1 propensity score matching (PSM) analysis. Results: A total of 29,512 cases of OC patients entered into the study, including 89 patients with brain metastases of ovarian cancer, which accounted for 0.30% of the entire cohort and 12.02% of the metastatic disease subset. We identified eight factors, including laterality, histology, surgery, radiotherapy, chemotherapy, and extracranial metastatic sites to bone, liver, and lung, as predictors of OCBM based on multivariable logistic regression among the entire cohort. The median survival time of OCBM was 2.0 months, and the interquartile range was 2.0-10.0 mo. The patients who received comprehensive treatment had better prognosis. Based on the multivariable Cox model, marital status, surgery, chemotherapy, and extensive therapy (including RSC, SC, and RC) were identified as predictors of OS. Besides, a new factor (brain metastasis) was identified by 1:1 PSM -based multiple Cox regression, apart from the above prognostic factors for OS. Conclusions: This study provided a population-based estimate of the proportion and prognosis for newly diagnosed ovary cancer with brain metastases. These findings may add materials to guidelines for preliminary screening and optimal treatment of OCBM patients. Ivyspring International Publisher 2020-05-18 /pmc/articles/PMC7255353/ /pubmed/32489480 http://dx.doi.org/10.7150/jca.44494 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Xi, Sujuan Li, Zaiyi Guo, Quan Lin, Wenjing Liang, Xiaokun Ma, Lin Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study |
title | Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study |
title_full | Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study |
title_fullStr | Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study |
title_full_unstemmed | Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study |
title_short | Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study |
title_sort | prognostic factors among brain metastases in newly diagnosed ovary cancer: a large real-world study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255353/ https://www.ncbi.nlm.nih.gov/pubmed/32489480 http://dx.doi.org/10.7150/jca.44494 |
work_keys_str_mv | AT xisujuan prognosticfactorsamongbrainmetastasesinnewlydiagnosedovarycanceralargerealworldstudy AT lizaiyi prognosticfactorsamongbrainmetastasesinnewlydiagnosedovarycanceralargerealworldstudy AT guoquan prognosticfactorsamongbrainmetastasesinnewlydiagnosedovarycanceralargerealworldstudy AT linwenjing prognosticfactorsamongbrainmetastasesinnewlydiagnosedovarycanceralargerealworldstudy AT liangxiaokun prognosticfactorsamongbrainmetastasesinnewlydiagnosedovarycanceralargerealworldstudy AT malin prognosticfactorsamongbrainmetastasesinnewlydiagnosedovarycanceralargerealworldstudy |